Michael Kloss

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.

Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD.

PHC Corporation engages in the development, manufacture, sale and service of medical devices, and healthcare information technology (IT) and life sciences. It carries the business brands Medicom and PHCbi. The company was founded on November 21, 1969 and is headquartered in Tokyo, Japan.

API Corp. engages in the manufacture and sale of drug substances, pharmaceutical formulation intermediates, investigational drug manufacturing and others. The company was founded in 2002 and is headquartered in Tokyo, Japan.

Part of Ernst & Young Global Ltd., Ernst & Young Audit SAS (France) is a French company that provides auditing and accounting services. The company is based in Courbevoie, France. Founded in 1987.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan.

French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France.

INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages.

Compas SA wholesales chemical products. The company was founded on April, 19 1949 and is headquartered in Gueux, France.

Part of Edwards Lifesciences Corp., Edwards Lifesciences SAS is a French company that engages in wholesale distribution of pharmaceutical products. The company is based in Guyancourt, France.

Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France.

BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon.

Famar Health Care Services is a Greek European company that specializes in pharmaceutical manufacturing and development services. The company is based in Athens, Greece. With a legacy of 70 years of technology expertise, Famar is a leading provider in the industry. and has subsidiaries in Spain. Kostas Rengis has been the CEO of the company since 2021.

Life Science Institute, Inc. provides clinical testing and pharmaceutical development support activities. The company is headquartered in Tokyo, Japan.

Lunaphore Technologies SA develops tissue diagnostics solutions. Its products include in vitro diagnostics, automated staining instruments, and consumables. The company was founded by Ata Tuna Ciftlik, Diego Gabriel Dupouy, and D?borah Heintze in April 2014 and is headquartered in Tolochenaz, Switzerland.

Bayer Healthcare SAS manufactures pharmaceutical products. The company was founded on July 23, 2007 and is headquartered in Loos, France.

Part of PHC Holdings Corp., Ascensia Diabetes Care France SAS is a French company that manufactures glycemic self-monitoring devices for people with diabetes. The company is based in Neuilly-sur-Seine, France.

Stellate Therapeutics, Inc. provides micro biome medicine. It also offers therapeutic products and associated diagnosis tools. The company was founded by Antoine Danchin and is headquartered in Paris, France.

Bowtie Life Insurance Co. Ltd. is an insurance company based in Hong Kong, HK. The company offers regular life insurance with a coverage of up to Hong Kong $8 million and a monthly premium of only Hong Kong $38. Bowtie aims to provide citizens with better protection at a lower price by using technology to reduce costs and offer "pure protection" insurance products. Bowtie also provides "zero commission" insurance plans such as voluntary medical insurance, life, and crisis, with monthly premiums as low as $100. Customers can enjoy outpatient services, premium reduction, or Bowtiecash. The Chinese company also offers a claim service for customers' loved ones who cannot claim for themselves due to injuries. The company was founded in 2017 by Ngan Fred, Kwan Yu Chan, who have been the CEOs since then.

Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland.

Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France.

eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation.

Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.

Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020.

Back to Basics, Inc. is an American company that is currently open for business. The private company prioritizes the safety of their staff and their families, especially those who are in high-risk groups. Customers are required to wear masks when entering the store.